LAWRENCE, Mass., Jan. 24, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that Robert G. Funari , most recently Chairman of Crescent Healthcare, has been appointed to its Board as an independent director.
Mr. Funari served as Chairman and Chief Executive Officer of Crescent Healthcare, a Walgreens Company providing integrated pharmacy and nursing solutions in alternate site settings from 2004 to 2012. Prior to joining Crescent, Mr. Funari was Executive Vice President and Chief Operating Officer (1993-1996) at Syncor International Corporation, a publicly-traded radiopharmacy services company, where he also served as President and Chief Executive Officer (1996-2003). Mr. Funari was Executive Vice President and General Manager of the Drug Company for McKesson, Inc. and spent more than 18 years in a broad range of leadership positions at Baxter International.
"With more than 40 years of executive leadership, particularly in the healthcare industry, and a proven track record of strategic planning and implementation, Bob will be valuable in helping us advance our strategic initiatives to build shareholder value for the future," said Jeffrey Burbank , Chief Executive Officer, NxStage Medical, Inc.
Funari remarked, "NxStage has the technology, talent and resources to make significant advancements in the delivery of renal care for the benefit of dialysis patients around the world. I believe that the Company is committed to strategic, patient and market-focused initiatives that will enable it to build on its positi